Prostate Cancer and PSA Follow-Up: Oregon Malpractice

A prostate-specific antigen (PSA) test is a common blood test that helps doctors watch for prostate cancer. When a result comes back high, what happens next matters. In some cases, an elevated or rising PSA is noted but never acted on. The patient is not told, no repeat test is ordered, or no referral is made. Months or years later, the cancer is found at a later stage. This article explains how that kind of follow-up failure is viewed under Oregon medical malpractice law.

What the PSA test can and cannot tell you

PSA is a protein made by cells in the prostate gland, both normal cells and cancer cells. A higher PSA level raises the chance that cancer is present, but there is no set number that proves a man does or does not have prostate cancer.¹ Many benign conditions can also push PSA up. An infection or inflammation of the prostate, a recent prostate biopsy, vigorous cycling, and even ejaculation can raise PSA for a time.² Because of this, a single high result is not a diagnosis. It is a signal that usually calls for a closer look.

PSA screening is genuinely debated

It is important to be fair about the science. Whether to screen with PSA at all is a real medical debate. The U.S. Preventive Services Task Force gives PSA screening a "C" grade for men ages 55 to 69, meaning the choice to screen should be an individual one made with a doctor. For men 70 and older, the Task Force recommends against routine PSA screening.³ Screening carries real downsides, including false alarms, biopsies that turn out negative, and finding slow-growing cancers that may never cause harm.

So a malpractice concern is usually not about whether a man was screened in the first place. That is a judgment call. The concern is what happened after a test was actually done and came back abnormal.

When following up on a result becomes a duty

Once a PSA result exists, standard practice is to make sense of it. Doctors often look for a trend of rising PSA over time rather than react to one number. When a PSA level stays high on a repeat test, or rises quickly, further evaluation such as imaging or a prostate biopsy may be recommended.⁴ A common first step is simply to repeat the PSA in about six to eight weeks to confirm the reading before deciding what to do next.⁴

If the numbers still point toward cancer, a biopsy is the only way to know for sure whether prostate cancer is present.⁵ The follow-up chain — notice the result, repeat or investigate it, and refer for biopsy when warranted — is where breakdowns tend to cause harm.

How PSA mismanagement can delay a diagnosis

Several gaps can turn an abnormal result into a late diagnosis:

• Failure to act on a rising or elevated PSA. The number is in the chart, but no repeat test, imaging, or referral follows.
• Failure to refer for biopsy. Results keep climbing, yet the patient is never sent to a urologist to confirm what is going on.
• Lost-to-follow-up results. A result comes back after a visit, is never communicated to the patient, and no one closes the loop.

Prostate cancer often grows slowly, but not always. When follow-up stalls, a cancer that might have been caught early can advance. A delay can mean the difference between disease that is still contained and disease that has spread, which can change treatment options and outlook.

Oregon's medical malpractice standard of care

Not every bad outcome is malpractice. Oregon law asks whether the provider met the professional standard of care. Under ORS 677.095, a physician must use "that degree of care, skill and diligence that is used by ordinarily careful physicians in the same or similar circumstances."⁶ The question is not whether a specialist in hindsight would have done more. It is whether a reasonably careful physician in similar circumstances would have handled the result differently.

In a PSA case, a lawyer and a medical expert would look at what the results showed, when they came in, what the provider knew, and whether the response matched what careful physicians ordinarily do. Proving a claim also requires showing that the failure caused added harm — for example, that acting sooner would more likely than not have led to an earlier diagnosis and better options.

Filing deadlines in Oregon

Oregon sets firm time limits on medical malpractice claims. Under ORS 12.110(4), an action must be started within two years from the date the injury is first discovered, or reasonably should have been discovered.⁷ This "discovery rule" matters in cancer cases, because a patient may not learn that a result was mishandled until the diagnosis finally comes.

There is also an outer limit. The same statute requires that the action be started within five years from the date of the treatment or omission it is based on, regardless of when the injury is discovered — unless fraud or concealment applies.⁷ Because these deadlines can be complex, and because the clock may already be running, the timing of any specific situation is something to review carefully with an Oregon attorney.

Talking to an Oregon attorney

If you believe a rising or elevated PSA was ignored, or that abnormal results were never followed up, an Oregon attorney can review the records and the timeline. This article is meant to explain how Oregon law approaches these cases, not to tell you whether you have a claim. Every situation depends on its own facts.

This article is educational

This article describes Oregon law in general terms. It is not legal advice and does not create an attorney-client relationship.

Time limits matter. Most Oregon personal-injury and auto-accident claims must be filed within two years of the injury or accident. Medical malpractice claims must be filed within two years of when you knew or reasonably should have known of the negligence, with an outer limit of five years from the act itself (with a fraud exception). Wrongful death claims must be filed within three years of the date of death. Claims against public bodies (cities, counties, state agencies, public hospitals) require a notice of claim within 180 days. Missing these deadlines typically ends a case.

If you think you may have a claim, call Huegli Law at 971-317-6436 for a free case review. Todd Huegli is licensed in Oregon and consults on cases in Oregon only.

Footnotes

1. Prostate Cancer Tests to Diagnose and Stage. American Cancer Society. https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/tests.html ↩

2. Prostate-Specific Antigen (PSA) Test. National Cancer Institute. https://www.cancer.gov/types/prostate/psa-fact-sheet ↩

3. Prostate Cancer: Screening. U.S. Preventive Services Task Force. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening ↩

4. Prostate-Specific Antigen (PSA) Test. National Cancer Institute. https://www.cancer.gov/types/prostate/psa-fact-sheet ↩ ↩²

5. Prostate Cancer Tests to Diagnose and Stage. American Cancer Society. https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/tests.html ↩

6. ORS 677.095 - Degree of care and skill required. Oregon Public Law. https://oregon.public.law/statutes/ors_677.095 ↩

7. ORS 12.110 - Actions for certain injuries to person not arising on contract. Oregon Public Law. https://oregon.public.law/statutes/ors_12.110 ↩ ↩²